AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42

Authors: Baglin, I Daveu, C Lancelot, JC Bureau, R Dauphin, F Pfeiffer, B Renard, P Delagrange, P Rault, S
Citation: I. Baglin et al., First tricyclic oximino derivatives as 5-HT3 ligands, BIOORG MED, 11(4), 2001, pp. 453-457

Authors: Regrigny, O Delagrange, P Scalbert, E Atkinson, J Chillon, JM
Citation: O. Regrigny et al., Melatonin increases pial artery tone and decreases the lower limit of cerebral blood flow autoregulation, FUN CL PHAR, 15(4), 2001, pp. 233-238

Authors: Regrigny, O Dupuis, F Atkinson, J Liminana, P Scalbert, E Delagrange, P Chillon, JM
Citation: O. Regrigny et al., Cerebral arteriolar structure and function in pinealectomized rats, AM J P-HEAR, 281(4), 2001, pp. H1476-H1480

Authors: Yang, Q Scalbert, E Delagrange, P Vanhoutte, PM O'Rourke, ST
Citation: Q. Yang et al., Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries, AM J P-HEAR, 280(1), 2001, pp. H76-H82

Authors: Vandeputte, C Giummelly, P Atkinson, J Delagrange, P Scalbert, E Capdeville-Atkinson, C
Citation: C. Vandeputte et al., Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration, AM J P-HEAR, 280(1), 2001, pp. H420-H425

Authors: Tom, B De Vries, P Heiligers, JPC Willems, EW Scalbert, E Delagrange, P Saxena, P
Citation: B. Tom et al., The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity, CEPHALALGIA, 21(6), 2001, pp. 656-663

Authors: Van den Top, M Buijs, RM Ruijter, JM Delagrange, P Spanswick, D Hermes, MLHJ
Citation: M. Van Den Top et al., Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm, NEUROSCIENC, 107(1), 2001, pp. 99-108

Authors: Rezaie, R Joseph, B Bremner, JB Delagrange, P Kopp, C Misslin, R Pfeiffer, B Renard, P Guillaumet, G
Citation: R. Rezaie et al., 5-substituted 3,4-dihydro-3-amino-2H-1-benzopyran derivatives: synthesis and interaction with serotoninergic receptors, J PHARM PHA, 53(7), 2001, pp. 959-968

Authors: Brydon, L Petit, L Delagrange, P Strosberg, AD Jockers, R
Citation: L. Brydon et al., Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes, ENDOCRINOL, 142(10), 2001, pp. 4264-4271

Authors: Nosjean, O Nicolas, JP Klupsch, F Delagrange, P Canet, E Boutin, JA
Citation: O. Nosjean et al., Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2, BIOCH PHARM, 61(11), 2001, pp. 1369-1379

Authors: Conway, S Mowat, ES Drew, JE Barrett, P Delagrange, P Morgan, PJ
Citation: S. Conway et al., Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT1 receptor, BIOC BIOP R, 282(5), 2001, pp. 1229-1236

Authors: Boutin, JA Lahaye, C Pegurier, C Nicolas, JP Fauchere, JL Langlois, M Renard, P Delagrange, P Canet, E
Citation: Ja. Boutin et al., Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries, J RECEPT SI, 20(1), 2000, pp. 105-118

Authors: Charton, I Mamai, A Bennejean, C Renard, P Howell, EH Guardiola-Lemaitre, B Delagrange, P Morgan, PJ Viaud, MC Guillaumet, G
Citation: I. Charton et al., Substituted oxygenated heterocycles and thio-analogues: Synthesis and biological evaluation as melatonin ligands, BIO MED CH, 8(1), 2000, pp. 105-114

Authors: Pegurier, C Curtet, S Nicolas, JP Boutin, JA Delagrange, P Renard, P Langlois, M
Citation: C. Pegurier et al., Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt(1) and MT2 receptors, BIO MED CH, 8(1), 2000, pp. 163-171

Authors: Merle, A Delagrange, P Renard, P Lesieur, D Cuber, JC Roche, M Pellissier, S
Citation: A. Merle et al., Effect of melatonin on motility pattern of small intestine in rats and itsinhibition by melatonin receptor antagonist S 22153, J PINEAL R, 29(2), 2000, pp. 116-124

Authors: Li, XM Liu, XH Filipski, E Metzger, G Delagrange, P Jeanniot, JP Levi, F
Citation: Xm. Li et al., Relationship of atypical melatonin rhythm with two circadian clock outputsin B6D2F(1) mice, AM J P-REG, 278(4), 2000, pp. R924-R930

Authors: Merle, A Faucheron, JL Delagrange, P Renard, P Roche, M Pellissier, S
Citation: A. Merle et al., Nycthemeral variations of cholecystokinin action on intestinal motility inrats: effects of melatonin and S 20928, a melatonin receptor antagonist, NEUROPEPTID, 34(6), 2000, pp. 385-391

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Misslin, R
Citation: C. Kopp et al., Reentrainment of the spontaneous locomotor activity rhythm to a daylight reversal in C57BL/6 and C3H/He mice: Implication of melatonin, PHYSL BEHAV, 70(1-2), 2000, pp. 171-176

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Misslin, R
Citation: C. Kopp et al., Anxiolytic-like properties of melatonin receptor agonists in mice: Involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness, NEUROPHARM, 39(10), 2000, pp. 1865-1871

Authors: Ting, N Thambyraja, A Sugden, D Scalbert, E Delagrange, P Wilson, VG
Citation: N. Ting et al., Pharmacological studies on the inhibitory action of melatonin and putativemelatonin analogues on porcine vascular smooth muscle, N-S ARCH PH, 361(3), 2000, pp. 327-333

Authors: Jellimann, C Mathe-Allainmat, M Andrieux, J Kloubert, S Boutin, JA Nicolas, JP Bennejean, C Delagrange, P Langlois, M
Citation: C. Jellimann et al., Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors, J MED CHEM, 43(22), 2000, pp. 4051-4062

Authors: Ferry, G Loynel, A Kucharczyk, N Bertin, S Rodriguez, M Delagrange, P Galizzi, JP Jacoby, E Volland, JP Lesieur, D Renard, P Canet, E Fauchere, JL Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase (vol 275, pg 8794, 2000), J BIOL CHEM, 275(50), 2000, pp. 39799-39799

Authors: Nosjean, O Ferro, M Coge, F Beauverger, P Henlin, JM Lefoulon, F Fauchere, JL Delagrange, P Canet, E Boutin, JA
Citation: O. Nosjean et al., Identification of the melatonin-binding site MT3 as the quinone reductase 2, J BIOL CHEM, 275(40), 2000, pp. 31311-31317

Authors: Conway, S Drew, JE Mowat, ES Barrett, P Delagrange, P Morgan, PJ
Citation: S. Conway et al., Chimeric melatonin mt(1) and melatonin-related receptors - Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt(1) receptor, J BIOL CHEM, 275(27), 2000, pp. 20602-20609

Authors: Ferry, G Loynel, AM Kucharczyk, N Bertin, S Rodriguez, M Delagrange, P Galizzi, JP Jacoby, E Volland, JP Lesieur, D Renard, P Canet, E Fauchere, JL Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase, J BIOL CHEM, 275(12), 2000, pp. 8794-8805
Risultati: 1-25 | 26-42